Purchase Order HT941024P0282

Award Date 10/1/24
Potential Completion Date 9/30/29
Potential Value $227K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics, is for $982,402.00 in Germline PGx Molecular Testing services. The award was made by the Department of Veterans Affairs (VA) Strategic Acquisition Center Frederick on September 30, 2024, with a period of performance through September 29, 2025. This is a firm fixed-price delivery order contract with no set-aside designation. Baylor Genetics is a for-profit limited liability company that...
This is a $11,387,675.00 Firm Fixed Price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center in Frederick, MD to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The contract is for "GERMLINE PGX MOLECULAR TESTING - YEAR 2" and has an ultimate completion date of September 29, 2026. Baylor Genetics is a for-profit limited liability company that specializes in clinical genetic testing and precision...
This firm fixed-price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian agency under the Department of Health and Human Services, to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The $231,600.00 contract is for clinical testing services and has an ultimate completion date of September 28, 2026. The original solicitation, posted on September 3, 2025, sought clinical testing services under the Medical Laboratories NAICS...
This federal contract award, valued at $6,361,900.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The contract is for whole genome sequencing services, including the sequencing of 1,400 whole genomes with delivery of raw data, and 250 whole genomes with delivery of data, interpretation, and reports. The contract was awarded as a firm-fixed-price purchase order with no set-aside...
This is a $235,200 firm fixed-price purchase order awarded by the National Human Genome Research Institute, part of the National Institutes of Health within the Department of Health and Human Services, to Baylor Miraca Genetics Laboratories LLC (dba Baylor Genetics) for whole genome sequencing and clinical testing services in support of the Undiagnosed Disease Program (UDP). The contract has an ultimate completion date of August 22, 2025 and was awarded on August 23, 2024. No set-aside...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health, to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The $68,900.00 contract is for chromosomal microarray analysis services, with a period of performance through April 17, 2023. Baylor Genetics is a for-profit limited liability company that specializes in...
This is a $44,250 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics. The contract is for microarray testing services to support NIAID's infectious disease research, which aligns with the NIH's mission of advancing medical research to improve public health. This contract is not associated with a larger...
Baylor Genetics was awarded a $59,000 purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide clinical single nucleotide polymorphism and comparative genomic hybridization microarray testing services. The firm fixed price contract runs from July 14, 2023 through September 30, 2023 and will be performed in Houston, Texas. No subcontractors or set aside designations were identified. The testing services align with NIH's mission to...
This is a $730,306.58 firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Baylor College of Medicine. The contract provides genetic testing services, including whole exome sequencing, comparative genomic hybridization, and whole genome sequencing coupled with RNA sequencing, in support of NIAID's Centralized Sequencing Initiative to obtain genetic testing...
The U.S. Department of Veterans Affairs (VA) awarded Baylor College of Medicine, a private non-profit university, a $855,485.20 firm fixed-price delivery order contract for gene sequencing services. The contract has an ultimate completion date of August 31, 2024 and was awarded on June 3, 2022. This delivery order is part of a larger indefinite delivery contract with the VA to provide on-site liver and kidney transplant services at the Michael E. DeBakey VA Medical Center in Houston, Texas....

This federal contract award is for whole exome sequencing and whole genome sequencing laboratory testing services for the Naval Medical Center San Diego. The $227,275.00 firm fixed-price purchase order was awarded to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics, a for-profit limited liability company that specializes in clinical genetic testing and precision medicine. The contract has an ultimate completion date of September 30, 2029. Baylor Genetics has also been awarded an Indefinite Delivery, Indefinite Quantity (IDIQ) contract by the Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick, valued at $99,032,828.20, for germline pharmacogenomics molecular testing services to support the VA's Oncology, Medical Genetics, and Pharmacogenomics practice areas. This contract represents a significant opportunity for Baylor Genetics to provide comprehensive genetic testing services to the VA enterprise. The contract is not designated as a set-aside.

Generated 9/25/25, 11:01 AM